Bloomage BioTechnology Corporation Limited (SHA:688363)
China · Delayed Price · Currency is CNY 39.52
-0.48 (-1.20%)
May 21, 2026, 3:00 PM CST
SHA:688363 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 254.82 | 292.06 | 174.27 | 592.56 | 970.92 | 782.33 |
Depreciation & Amortization | 350.09 | 350.09 | 300 | 264.65 | 213.61 | 154.33 |
Other Amortization | 40.91 | 40.91 | 30.18 | 27.74 | 15.04 | 6.96 |
Loss (Gain) From Sale of Assets | -0.22 | -0.22 | 0.12 | 3.42 | 0.49 | -0.04 |
Asset Writedown & Restructuring Costs | 5.22 | 5.22 | 74.95 | 1.87 | 0.28 | 33.73 |
Loss (Gain) From Sale of Investments | -14.15 | -14.15 | 11.48 | 17.41 | -11.77 | -28.04 |
Provision & Write-off of Bad Debts | 41.46 | 41.46 | 26.01 | 7.6 | 15.36 | 5.78 |
Other Operating Activities | 293.66 | 102.49 | 85.03 | 30.02 | -1.72 | -1.65 |
Change in Accounts Receivable | -38.99 | -38.99 | -86.55 | 54.48 | -98.43 | -36.27 |
Change in Inventory | 162.15 | 162.15 | -141.49 | 13.88 | -437.82 | -218.53 |
Change in Accounts Payable | -327.97 | -327.97 | 98.06 | -321.54 | -72.85 | 613.39 |
Change in Other Net Operating Assets | -5.28 | -5.28 | 11.54 | 42.5 | 103.85 | 114.25 |
Operating Cash Flow | 781.39 | 627.45 | 564.51 | 699.65 | 635.19 | 1,276 |
Operating Cash Flow Growth | 54.22% | 11.15% | -19.32% | 10.15% | -50.22% | 80.97% |
Capital Expenditures | -331.44 | -325.68 | -721.39 | -1,030 | -696.41 | -784.21 |
Sale of Property, Plant & Equipment | 2.08 | 2.07 | 0.21 | 0 | 1.24 | 0.01 |
Cash Acquisitions | - | - | - | - | -155.15 | -138.09 |
Divestitures | - | - | - | - | 0.12 | - |
Investment in Securities | 40.83 | 48.32 | 227.02 | 403.67 | -11.17 | -100.1 |
Other Investing Activities | -49.42 | 10.42 | 32.79 | 13.78 | 25.15 | 32.53 |
Investing Cash Flow | -337.95 | -264.87 | -461.37 | -612.88 | -836.22 | -989.86 |
Long-Term Debt Issued | - | 310.28 | 149.9 | - | 137.83 | 174 |
Total Debt Issued | 258.49 | 310.28 | 149.9 | - | 137.83 | 174 |
Long-Term Debt Repaid | - | -259.02 | -160.4 | -173.91 | -84.62 | -54.32 |
Total Debt Repaid | -224.38 | -259.02 | -160.4 | -173.91 | -84.62 | -54.32 |
Net Debt Issued (Repaid) | 34.1 | 51.26 | -10.51 | -173.91 | 53.21 | 119.68 |
Issuance of Common Stock | - | - | - | 51.72 | 84.21 | - |
Repurchase of Common Stock | - | - | -114.08 | -105.89 | - | - |
Common Dividends Paid | -56.75 | -56.08 | -185.93 | -305.48 | -242.86 | -201.01 |
Other Financing Activities | 5.45 | 2.52 | - | 6 | -64.71 | 9.98 |
Financing Cash Flow | -17.2 | -2.3 | -310.52 | -527.57 | -170.16 | -71.36 |
Foreign Exchange Rate Adjustments | -9.82 | 4 | 7.81 | 10.56 | 29.56 | -19.85 |
Net Cash Flow | 416.42 | 364.28 | -199.57 | -430.24 | -341.63 | 194.99 |
Free Cash Flow | 449.95 | 301.77 | -156.88 | -330.68 | -61.22 | 491.85 |
Free Cash Flow Margin | 11.39% | 7.19% | -2.92% | -5.44% | -0.96% | 9.94% |
Free Cash Flow Per Share | 0.95 | 0.63 | -0.32 | -0.69 | -0.13 | 1.02 |
Cash Income Tax Paid | 235.66 | 226.04 | 480.27 | 550.54 | 770.79 | 539.9 |
Levered Free Cash Flow | 376.59 | 221.1 | -288.5 | -624.83 | -240.37 | 940.17 |
Unlevered Free Cash Flow | 380.6 | 225.11 | -282.77 | -618.13 | -231.29 | 947.09 |
Change in Working Capital | -190.41 | -190.41 | -137.54 | -245.63 | -567.02 | 322.66 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.